D-0295-2025 Class II Ongoing
Recall Details
- Product Type
- Drugs
- Report Date
- April 2, 2025
- Initiation Date
- March 6, 2025
- Termination Date
- N/A
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- N/A
Product Description
fentaNYL Citrate PF 200 mcg/100 mL (2 mcg/ml) /0.1% Bupivacaine HCl 100 mg/100 mL (1 mg/mL), 100 ml in NS Yellow CADD FSFF, Injection for Epidural Use (Not intended For IV Use), Compounded, For Institutional or Office Use Only, QuVa Pharma, 1075 West Park One Drive, Suite 100, Sugar Land, Tx 77478. NDC: 70092-1255-75
Reason for Recall
Lack of Assurance of Sterility
Distribution Pattern
U.S. Nationwide
Code Information
Lots: 10140259, 10140539, 10140687, 10140688; Exp 04/24/2025